Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 16;3(1):150-153.
doi: 10.1016/j.jaccao.2020.11.015. eCollection 2021 Mar.

Ventricular Arrhythmias Due to Glomangiosarcoma Cardiac Metastases

Chiara Lestuzzi  1 , Giammaria Miolo  2 , Lucia Tartuferi  1 , Rosa Pecoraro  3 , Antonino De Paoli  4 , Ermanno Dametto  3 , Nadir Sitta  5 , Elisa Leiballi  3 , Fabio D Greco  6 , Angela Buonadonna  2
Affiliations
Review

Ventricular Arrhythmias Due to Glomangiosarcoma Cardiac Metastases

Chiara Lestuzzi et al. JACC CardioOncol. .
No abstract available

Keywords: antiangiogenic therapy; arrhythmia; cancer survivorship; cardiac magnetic resonance; cardiac masses; outcomes; palliative care; sarcoma; treatment; tyrosine kinase inhibitor.

PubMed Disclaimer

Conflict of interest statement

The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract
Figure 1
Figure 1
Holter Monitoring in May 2017 Holter monitor recording showing polymorphic ventricular tachycardia.
Figure 2
Figure 2
Computed Tomography and Radiotherapy Plan The masses (arrows) infiltrate the free wall and the apex of the right ventricle. The colored lines contour the intensity-modulated radiation dose (see scale on the left). The planned volume takes into account the cardiac motion to keep the metastases within the radiation field throughout the cardiac cycle.
See this image and copyright information in PMC

References

    1. Ravi V., Sanford E.M., Wang W.L. Antitumor response of VEGFR2- and VEGFR3-amplified angiosarcoma to pazopanib. J Natl Compr Canc Netw. 2016;14:499–502. - PubMed
    1. Boudou-Rouquette P., Tlemsani C., Blanchet B. Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review. Expert Opin Drug Metab Toxicol. 2016;12:1433–1444. - PubMed
    1. Colunga Biancatelli R.M., Congedo V., Calvosa L., Ciacciarelli M., Polidoro A., Iuliano L. Adverse reactions of amiodarone. J Geriatr Cardiol. 2019;16:552–566. - PMC - PubMed
    1. Ejaz K., Raza M.A., Aleem A., Maroof S., Tahir H. Glomangiosarcoma involving the heart with an unknown primary lesion. Cureus. 2018;10 - PMC - PubMed
    1. Goh C.H., Lim Y.P., Su J.W. Cardiopulmonary thromboembolism of epithelioid angiosarcoma arising from malignant phyllodes tumour of the breast. J Clin Pathol. 2014;67:450–454. - PubMed

LinkOut - more resources